The European Medicines Agency (EMA) has received an application for conditional approval of the corona vaccine developed by Johnson & Johnson.
Johnson & Johnson is the fourth vaccine manufacturer to apply for approval in Europe.
The EMA has already gone through parts of the vaccine documentation, and the vaccine could be temporarily approved in mid-March.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at email@example.com